BioCentury
ARTICLE | Clinical News

Anipryl formulation of l-deprenyl: Completed its Phase III equivalent filing with the FDA

October 2, 1995 7:00 AM UTC

Deprenyl Animal Health Inc. (DAHI) Product: Anipryl formulation of l-deprenyl Indication: Cushing's disease in aging dogs Status: Completed its Phase III equivalent filing with the FDA ...